- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Third Rock Ventures V, L.P.
- Signature - Title
- /s/ Kevin Gillis - Kevin Gillis, Chief O.O of TRV GP V, LLC, general partner of Third Rock Ventures GP V, L.P., general partner of Third Rock Ventures V, L.P.
- Location
- Boston, MA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Third Rock Ventures V, L.P..
Follow Filing Activity
Follow Third Rock Ventures V, L.P. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Third Rock Ventures V, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | Common Stock, $0.001 par value per share | 20% | $81,198,952 | 7,135,233 | Third Rock Ventures V, L.P. | 31 Dec 2024 | ||
| SEPN | Septerna, Inc. | Common Stock, $0.001 par value per share | 14% | $43,509,137 | 6,215,591 | 0% | Third Rock Ventures V, L.P. | 31 Mar 2025 |
Schedules 13D/G Reported by Third Rock Ventures V, L.P.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.